跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 琤
教授
醫學生物技術暨檢驗學系
https://orcid.org/0000-0001-8220-1815
電話
02-2826-7149, 02-2826-7000 #65923
電子郵件
chengh
nycu.edu
tw
網站
https://mt.ym.edu.tw/files/11-1250-1560.php
h-index
h10-index
h5-index
1264
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
769
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
438
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2005
2024
每年研究成果
概覽
指紋
網路
研究成果
(57)
類似的個人檔案
(6)
指紋
查看啟用 Cheng Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Hepatitis delta Antigen
86%
Diet-induced
86%
COVID-19
82%
Induced Apoptosis
76%
Non-alcoholic Fatty Liver Disease (NAFLD)
75%
Hepatitis delta Virus
68%
Gut Microbiota
58%
Amphiregulin
56%
Metabolic Dysfunction
56%
Hepatitis B Virus
55%
MDA-MB-231
55%
High-fat Diet
53%
Hepatic Steatosis
50%
Temozolomide
49%
Metabolic Disorders
49%
Insulin Resistance
48%
Apoptosis
47%
Glucagon-like
46%
HDAg
46%
Obesity
45%
Nuclear Export Signal
45%
Temozolomide Resistance
44%
Momordica Cochinchinensis
44%
Diet-induced Obese Mice
43%
ε-viniferin
42%
D-glucose
42%
Galloyl
42%
Penta
42%
Chondrosarcoma Cells
42%
Diet-induced Obesity
42%
Gac Aril
42%
Diabetic Mice
42%
Doxorubicin
41%
Clathrin
34%
Hepatitis B Virus Infection
34%
Type 2 Diabetes Mellitus (T2DM)
33%
Glioblastoma multiforme
32%
Knockdown
31%
Glioblastoma Cells
30%
Chrysin
30%
Cell Migration
29%
Chymotrypsin
28%
Interacting Proteins
28%
3C-like Protease Inhibitors
28%
Hepatitis D Virus
28%
Non-small Cell Lung Cancer Cells
28%
Ugonin J
28%
Human Liver Cancer Cells
28%
X-ray
28%
Curcumin
28%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
70%
SARS Coronavirus
70%
Nonalcoholic Fatty Liver
66%
Hepatitis B Virus
59%
Clathrin
59%
Amphiregulin
56%
Doxorubicin
56%
Temozolomide
56%
Breast Cancer
56%
Fatty Liver
54%
Receptor
52%
Diet Induced Obesity
49%
Hepatitis Delta Virus
46%
Glucagon-Like Peptide-1
45%
Malignant Neoplasm
44%
Chondrosarcoma
42%
Non Small Cell Lung Cancer
35%
Chrysin
35%
Hepatitis B
34%
Epigallocatechin Gallate
33%
Hepatitis Delta Antigen
30%
Proteinase Inhibitor
29%
Ergosterol
28%
Curcumin
28%
Zebra Fish
28%
Intestine Flora
28%
Carotenoid
28%
Infection
27%
Insulin Resistance
27%
Chymotrypsin
27%
Diseases
25%
Osteosarcoma
24%
Virus Infection
22%
Proteinase
21%
Clathrin Heavy Chain
21%
Protein Kinase B
21%
Vimentin
21%
Resveratrol
21%
Nude Mouse
21%
Anti-Inflammatory Drug
21%
Antivirus Agent
20%
Dyslipidemia
19%
Lung Cancer
18%
S Phase Kinase Associated Protein 2
18%
Hyperlipidemia
17%
Non Insulin Dependent Diabetes Mellitus
17%
Drug Resistance
17%
microRNA
17%
Cell Viability
16%
Triple Negative Breast Cancer
16%
Medicine and Dentistry
Diet Induced Obesity
100%
High Fat Food
83%
Nonalcoholic Fatty Liver
72%
Gut Microbiota
70%
Fatty Liver
62%
Doxorubicin
56%
Insulin Resistance
52%
Metabolic Disorder
46%
Water-Electrolyte Imbalance
42%
Amphiregulin
42%
Chondrosarcoma
42%
Programmed Cell Death
33%
Adipocyte
32%
Cell Signaling Pathway
29%
Cell Migration
29%
Glioblastoma
28%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Momordica
28%
Carotenoid
28%
Taste Bud
28%
Hyperlipidemia
26%
Lipid Storage
25%
AMP-Activated Protein Kinase
20%
Maturity Onset Diabetes of the Young
19%
Breast Cancer
18%
Body Weight Gain
17%
Hyperglycemia
16%
Triple Negative Breast Cancer
16%
Cell Cycle Arrest
16%
Cell Cycle Checkpoint
16%
Liver Cirrhosis
16%
Dysbiosis
16%
Obesity
15%
Hepatocyte
14%
Apelin
14%
Vincristine
14%
Hepatitis Delta Virus
14%
Ginseng
14%
Drug Identification
14%
Matrilysin
14%
Amylose
14%
Nuclear Export
14%
Endoplasmic Reticulum Stress
14%
Experimental Diabetes Mellitus
14%
Mouth Squamous Cell Carcinoma
14%
Hepatitis Delta Antigen
14%
Lipoprotein Receptor
14%
S Phase Kinase Associated Protein 2
14%
Mitogen-Activated Protein Kinase
14%
Synbiotic
14%
